We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Mutation in Actin Domain Linked to Hearing Loss

By Biotechdaily staff writers
Posted on 14 Nov 2003
Researchers have found that a mutation occurring in the DFNA 20 gene, which is known to be involved in determining the structure of the inner ear, may be responsible for a type of inherited, age-related hearing loss (presbycusis).

Investigators at Michigan State University (East Lansing, USA) performed gene analysis on four families whose members displayed the onset of hearing-related communication problems as they neared the age of 30. More...
Writing in the November 2003 issue of the American Journal of Human Genetics, they stated that sequence analysis of the gamma-actin gene (ACTG1) showed missense mutations in highly conserved actin domains in all four families. These mutations altered amino acids that are normally conserved in all actins, from protozoa to mammals, and were not found in more than 100 chromosomes from normal-hearing individuals.

Much of the specialized ultrastructural organization of the cells in the cochlea is based on the actin cytoskeleton. The mutations in various binding domains of actin probably mildly interfere with bundling, gelation, polymerization, or myosin movement, and may cause hearing loss by hindering the repair or stability of cochlear cell structures damaged by noise or aging.
"Knowing what the gene is means that you can maybe move toward preventing hearing loss or, possibly, curing it,” said senior author Dr. Karen Friderici, associate professor of microbiology and molecular genetics at Michigan State University.



Related Links:
Michigan State University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Chromogenic Culture System
InTray™ COLOREX™ ECC
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.